AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service
Karachi, GlaxoSmithKline Pakistan, listed on the Main Board of the Pakistan Stock Exchange, observed a minor decrease in its stock value in today’s trading. The company’s shares were valued at Rs. 99.68, slightly lower than the previous weighted average rate of Rs. 101.39. GlaxoSmithKline Pakistan has a paid-up capital of 3,184.67 million rupees and saw a turnover of 4,915,500 shares. The pharmaceutical giant, established in 1953, reported earnings per share of 7.73 for the year 2022/2023.
Check Also
Ghariwal Cement Shareholder Reports Loss of Share Certificate
Karachi: A shareholder of Ghariwal Cement Limited has officially reported the loss of a share certificate covering fifteen shares, according to a recent notice issued by the company. The lost certificate, under Folio No. 2489, was reported by M/s Moha...
The post Ghariwal Cement Shareholder Reports Loss of Share Certificate appeared first on .